| Acquirer | Target | Price |
|---|---|---|
| The Blackstone Group | TeamHealth Holdings | $6.1 billion |
| Karo Pharma AB | BioPhausia AB | $101.8 million |
| National Health Investors | Entrance-fee CCRC | $74 million |
| Celldex Therapeutics | Koltan Pharmaceuticals | $62.5 million |
| Mirgan Therapeutics | Signal Genetics | $40 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
